Connect with us
Patients with terminal leukemia who were not responding to treatment now have hope for a cure thanks to revumenib, a new experimental medication. In a long-awaited...
Scientists at ETH Zurich have made significant progress in developing a ready-to-use immunotherapy treatment for cancer. A synthetic protein modification can allow immune cells from any...
Cancer tumors are very effective at avoiding the immune system, making intervention difficult. A common gut bacterium has been genetically altered to seek out and destroy...
A drug study involving people with rectal cancer has remarkably eradicated the tumor in all 18 patients. Though small, the trial astounded practitioners in the field,...
According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent of patients...
Engineers at Duke University created a promising novel cancer treatment delivery system and demonstrated its efficacy against one of the disease’s most complex forms. The scientists...
Cancer is a condition that involves the development of abnormal cells in a certain part of the body that divide uncontrollably, so much so that it...
